| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Roche |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Genentech |
| Recipient: You |
| Company: Medscape |
| Recipient: You |
| Company: Clovis Oncology |
| Recipient: You |
| Company: Gerson Lehrman Group |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: OncLive |
| Recipient: You |
| Company: Targeted Oncology |
| Recipient: You |
| Company: Curio Sciences |
| Recipient: You |
| Company: GlaxoSmithKline |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Zentalis |
| Recipient: You |
| Company: EQRX |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: Vincerx Pharma |
| Recipient: You |
| Company: Mereo BioPharma |
| Recipient: You |
| Company: Immunogen |
| Recipient: You |
| Company: Mersana |
| Recipient: You |
| Company: NGM Biopharmaceuticals |
| Recipient: You |
| Company: Caris Life Sciences |
| Recipient: You |
| Company: Nuvectis Pharma |
| Recipient: You |
| Company: Seattle Genetics |
| Recipient: You |
| Company: Immunocore |
| Recipient: You |
| Company: ZielBio |
| Recipient: You |
| Company: Verastem |
| Recipient: You |
| Company: Gilead |
| Recipient: You |
| Company: Mersana |
| Recipient: You |
| Company: Nuvectis Pharma |
| Recipient: You |
| Company: pharma& |
| Recipient: You |
| Company: Daiichi Sankyo |
| Recipient: You |
| Company: Loxo/Lilly |
| Recipient: You |
| Company: Incyte |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Clovis Oncology |
| Recipient: Your Institution |
| Company: Roche/Genentech |
| Recipient: Your Institution |
| Company: GOG Foundation |
| Recipient: Your Institution |
| Company: Mereo BioPharma |
| Recipient: Your Institution |
| Company: Bio-Path |
| Recipient: Your Institution |
| Company: GlaxoSmithKline |
| Recipient: Your Institution |
| Company: Zentalis |
| Recipient: Your Institution |
| Company: Avenge Bio |
| Recipient: Your Institution |
| Company: Jazz Pharmaceuticals |
| Recipient: Your Institution |
| Company: Nuvectis Pharma |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Loxo/Lilly |
| Recipient: Your Institution |
| Company: Daiichi Sankyo Europe GmbH |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|